For the quarter ending 2026-03-31, SUNS had -$786,489 decrease in cash & cash equivalents over the period.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net income | 4,253,350 | 1,629,699 | 4,054,959 | 6,457,751 |
| Provision for current expected credit losses | 60,283 | 1,636,780 | -193,865 | 586,141 |
| Amortization of deferred financing costs | 344,109 | 150,967 | 153,091 | 173,931 |
| Accretion of deferred loan original issue discount and premium, net | 1,129,036 | 363,635 | 502,633 | 615,227 |
| Stock-based compensation | 369,962 | 256,174 | 260,307 | 502,687 |
| Interest drawn on loans | 4,124,684 | 4,409,365 | 4,840,726 | 8,103,971 |
| Pik interest | 32,847 | 21,704 | 13,613 | 10,405 |
| Interest receivable | 307,040 | 296,956 | -142,717 | 971,333 |
| Prepaid expenses and other assets | 23,772 | -573,421 | 376,047 | -248,624 |
| Accrued interest | 350,267 | 226,458 | 131,077 | 241,492 |
| Accrued management and incentive fees | 942,420 | -379,558 | 383,134 | 296,077 |
| Accrued direct administrative expenses | 351,136 | -555,219 | 162,278 | -40,337 |
| Accounts payable and other liabilities | 111,089 | 15,961 | -16,942 | -2,768 |
| Net cash provided by (used in) operating activities | 1,165,237 | -1,536,977 | -656,263 | -1,237,338 |
| Issuance of and fundings on loans | 85,191,929 | 56,321,595 | 27,838,688 | 120,416,392 |
| Principal repayment of loans | 70,099,302 | 8,820,283 | 31,153,945 | 11,542,613 |
| Net cash used in investing activities | -15,092,627 | -47,501,312 | 3,315,257 | -108,873,779 |
| Net transfers and distributions from (to) former parent | - | 0 | 0 | 0 |
| Proceeds from sale of common stock | 0 | 0 | 0 | 72,588,000 |
| Payment of offering costs - equity offering | 0 | 506,570 | 854,894 | 455,889 |
| Payment of financing costs | 232,803 | 380,885 | 2,000 | 217,731 |
| Borrowings on revolving credit facilities | 87,100,000 | 75,900,000 | 31,800,000 | 106,360,000 |
| Repayment of revolving credit facilities | 69,700,000 | 21,050,000 | 29,600,000 | 240,250,000 |
| Dividends paid to common shareholders | 4,026,296 | 4,026,296 | 4,026,353 | 6,968,412 |
| Net cash provided by (used in) financing activities | 13,140,901 | 49,936,249 | -2,683,247 | -68,944,032 |
| Net decrease in cash and cash equivalents | -786,489 | 897,960 | -24,253 | -179,055,149 |
| Cash and cash equivalents, beginning of period | 6,445,328 | 5,547,368 | 184,626,770 | - |
| Cash and cash equivalents, end of period | 5,658,839 | 6,445,328 | 5,547,368 | - |